Cover Image

Synthesis and cytotoxic screening of beta-boswellic acid derivatives

Ratna Kancana Wolfram, Anja Barthel-Niesen, Renate Schäfer, Lucie Heller, Ahmed Al-Harrasi, René Csuk

Abstract


Beta-boswellic acids are triterpenoids being generic to the plants of genus boswellia. Although they were shown to exhibit different biological activities, the cytotoxic potential of b-boswellic acid derivatives remained by and large unexploited. To expand the potential of these compounds we developed simple procedures for the interconversion of the most important b-boswellic acids 1-4 and prepared several other derivatives 5-48. These compounds were screened for their cytotoxic activity in sulforhodamine B assays employing several human tumor cell lines and nonmalignant mouse fibroblasts. One of these compounds, a difluoromethylester of 3-O-acetyl-11-keto-beta-boswellic acid 23, was cytotoxic for human breast adenocarcinoma cells MCF-7 (EC50 = 6.5 mM) while being significantly less cytotoxic for the mouse fibroblasts.

Full Text:

PDF

References


- Z. Y. Du, Z. L. Liu, Z. C. Ning, Y. Y. Liu, Z. Q. Song, C. Wang, A. P. Lu, Prospects of Boswellic Acids as Potential Pharmaceutics, Planta Med., 2015, 81, 259-271.

- H. Hussain, A. Al-Harrasi, R. Csuk, U. Shamraiz, I. R. Green, I. Ahmed, I. A. Khan, Z. Ali, Therapeutic potential of boswellic acids: a patent review (1990-2015), Expert Opin. Ther. Pat., 2017, 27, 81-90.

- P. R. Vuddanda, S. Singh, S. Velaga, Boswellic acid - Medicinal use of an ancient herbal remedy, J. Herb. Med., 2016, 6, 163-170.

- http://www.boswellin.com/page3.htm; last accessed 22.03.2017

- M. Alam, H. Khn, L. Samiullah, K. M. Siddique, A review on phytochemical and pharmacological studies of Kundur (Boswellia serrata Roxb ex Colebr) -a Unani drug, J. Appl. Pharmacl. Sci. 2012, 2, 148-156.

- R. Csuk, A. Niesen-Barthel, R. Schäfer, A. Barthel, A. Al-Harrasi, Synthesis and antitumor activity of ring A modified 11-keto-beta-boswellic acid derivatives, Eur. J. Med. Chem., 2015, 92, 700-711.

- R. Csuk, A. Barthel-Niesen, D. Ströhl, R. Kluge, C. Wagner, A. Al-Harrasi, Oxidative and reductive transformations of 11-keto-beta-boswellic acid, Tetrahedron, 2015, 71, 2025-2034.

- R. Csuk, A. Barthel-Niesen, A. Barthel, R. Schäfer, A. Al-Harrasi, 11-Keto-boswellic acid derived amides and monodesmosidic saponins induce apoptosis in breast and cervical cancers cells, Eur. J. Med. Chem., 2015, 100, 98-105.

- R. Kaur, S. Khan, R. Chib, T. Kaur, P.R. Sharma, J. Singh, B.A. Shah, S.C. Taneja, A comparative study of proapoptotic potential of cyano analogues of boswellic acid and 11-keto-boswellic acid, Eur. J. Med. Chem., 2011, 46, 1356-1366.

- P. H. Fan, T. Li, Y. Q. Ye, Q. Luo, H. Q. Yuan, H. X. Lou, Synthesis and cytotoxic activity of boswellic acid analogues, Phytochem. Lett., 2016, 18, 99-104.

- Y. Shao, C. T. Ho, C. K. Chin, V. Badmaev, W. Ma, M..T. Huang, Inhibitory activity of boswellic acids from Boswellia serrata against human leukemia HL-60 cells in culture, Planta Med., 1998, 64, 328-331.

- S. Kapoor, Boswellic acid and its inhibitory effect on tumor growth in systemic malignancies:

an emerging concept in oncology, Future Oncol., 2013, 9, 627-628.

- E. Ernst, Frankincense: systematic review, Brit. Med. J., 2008, 337, a2813

- J. Jauch, J. Bergmann, An efficient method for the large-scale preparation of 3-O-acetyl-11-oxo-beta-boswellic acid and other boswellic acids, Eur. J. Org. Chem., 2003, 4752-4756.

- X. D. Su, H. Lawrence, D. Ganeshapillai, A. Cruttenden, A. Purohit, M. J. Reed, N. Vicker, B. V. L. Potter, Novel 18 beta-glycyrrhetinic acid analogues as potent and selective inhibitors of 11 beta-hydroxysteroid dehydrogenases, Bioorgan. Med. Chem., 2004, 12, 4439-4457.

- S. Shibata, K. Takahashi, S. Yano, M. Harada, H. Saito, Y. Tamura, A. Kumagai, K. Hirabayashi, M. Yamamoto, N. Nagata, Chemical Modification of Glycyrrhetinic Acid in Relation to the Biological-Activities, Chem. Pharm. Bull., 1987, 35, 1910-1918.

- R. Pellegata, M. Pinza, G. Pifferi, C. Farina, A new reduction of the enone system of 18β-glycyrrhetic acid, Org. Prep. Proced. Int., 1999, 31, 181-187.

- M. Ota, P. J. Houghton, Boswellic acids with acetylcholinesterase inhibitory properties from frankincense, Nat. Prod. Commun., 2008, 3, 21-26.

- A. Henkel, N. Kather, B. Mönch, H. Northoff, J. Jauch, O. Werz, Boswellic acids from frankincense inhibit lipopolysaccharide functionality through direct molecular interference, Biochem. Pharmacol., 2012, 83, 115-121.

- U. Siemoneit, A. Koeberle, A. Rossi, F. Dehm, M. Verhoff, S. Reckel, T.J. Maier, J. Jauch, H. Northoff, F. Bernhard, V. Doetsch, L. Sautebin, O. Werz, Inhibition of microsomal prostaglandin E2 synthase-1 as a molecular basis for the anti-inflammatory actions of boswellic acids from frankincense, Br. J. Pharmacol., 2010, 162, 147-162.

- O. Werz, U. Siemoneit, A. Henkel, J. Jauch, N. Kather, Use of boswellic acids and synthetic boswellic acid derivatives for inhibiting microsomal prostaglandin E2 synthase and cathepsin G, 2009, DE102008015607A1; CAPLUS AN 2009:1260458.

- L. Ali, J. Hussain, A. Al-Rawahi, A. Al-Harrasi, Two New and Four Known Triterpenoids from Boswellia sacra Fluckiger, Rec. Nat. Prod., 2014, 8, 407-411.

- B. Mahajan, S. C. Taneja, V. K. Sethi, K. L. Dhar, 2 Triterpenoids from Boswellia-Serrata Gum Resin, Phytochemistry, 1995, 39, 453-455.

- S. Schweizer, A. F. W. von Brocke, S. E. Boden, E. Bayer, H. P. T. Ammon, H. Safayhi, Workup-dependent formation of 5-lipoxygenase inhibitory boswellic acid analogues, J. Nat. Prod., 2000, 63, 1058-1061.

- S. Rozen, I. Shahak, E. D. Bergmann, Reactions of Ring-C in Glycyrrhetic Acid-Derivatives, Israel J. Chem., 1975, 13, 234-246.

- K. Sasaki, N. Minowa, H. Kuzuhara, S. Nishiyama, Preventive effects of soyasapogenol B derivatives on liver injury in a concanavalin A-induced hepatitis model, Bioorgan. Med. Chem., 2005, 13, 4900-4911.

- M. Tsukahara, T. Nishino, I. Furuhashi, H. Inoue, T. Sato, H. Matsumoto, Synthesis and inhibitory effect of novel glycyrrhetinic acid derivatives on IL-1 beta-induced prostaglandin E-2 production in normal human dermal fibroblasts, Chem. Pharm. Bull., 2005, 53, 1103-1110.

- B. A. Shah, A. Kumar, P. Gupta, M. Sharma, V. K. Sethi, A. K. Saxena, J. Singh, G. N. Qazi, S. C. Taneja, Cytotoxic and apoptotic activities of novel amino analogues of boswellic acids, Bioorg. Med. Chem. Lett., 2007, 17, 6411-6416.

- R. Csuk, A. Niesen-Barthel, A. Barthel, R. Kluge, D. Ströhl, Synthesis of an antitumor active endoperoxide from 11-keto-beta-boswellic acid, Eur. J. Med. Chem., 2010, 45, 3840-3843.

- G. Bartoli, M. Bosco, M. Locatelli, E. Marcantoni, P. Melchiorre, L. Sambri, Unusual and unexpected reactivity of t-butyl dicarbonate (Boc(2)O)with alcohols in the presence of magnesium perchlorate. A new and general route to t-butyl ethers, Org. Lett., 2005, 7, 427-430.

- L. Heller, V. Perl, J. Wiemann, A. Al-Harrasi, R. Csuk, Amino(oxo)acetate moiety: A new functional group to improve the cytotoxicity of betulin derived carbamates, Bioorg. Med. Chem. Lett., 2016, 26, 2852-2854.

- A. P. Kozikowski, W. Tückmantel, Y. H. Hu, Studies in polyphenol chemistry and bioactivity. 3. Stereocontrolled synthesis of epicatechin-4 alpha,8-epicatechin, an unnatural isomer of the B-type procyanidins, J. Org. Chem., 2001, 66, 1287-1296.

- A. Anikin, M. Maslov, J. Sieler, S. Blaurock, J. Baldamus, L. Hennig, M. Findeisen, G. Reinhardt, R. Oehme, P. Welzel, Synthesis of a 1 alpha-amino-1-deoxy analogue of forskolin, Tetrahedron, 2003, 59, 5295-5305.

- P. Skehan, R. Storeng, D. Scudiero, A. Monks, J. Mcmahon, D. Vistica, J. T. Warren, H. Bokesch, S. Kenney, M. R. Boyd, New Colorimetric Cytotoxicity Assay for Anticancer-Drug Screening, J. Natl. Cancer Inst., 1990, 82, 1107-1112.

- F. A. Badria, B. R. Mikhaeil, G. T. Maatooq, M. A. Mohamed, Immunomodulatory triterpenoids from the oleogum resin of Boswellia carterii Birdwood, Z. Naturforsch., 2003, 58C, 505-516.




DOI: http://dx.doi.org/10.13171/mjc64/01707151548-csuk

Refbacks

  • There are currently no refbacks.


Copyright (c) 2017 Mediterranean Journal of Chemistry